(PharmaNewsWire.Com, September 07, 2017 ) The Global Cancer Immunotherapy Market was worth $ 62 Billion in 2016 and estimated to reach $ 111.23 Billion by the end of 2021 with a growing potential of 12.40 %.
Immunotherapy is a treatment option which uses certain parts of immune system to fight against various diseases such as cancer. Immunotherapy which is also known as biologic therapy can be performed by two ways. That are by stimulating ones own immune system to fight against the disease by attacking defected cancer cells, and by giving constituents of immune system from outside such as synthetic proteins into the body to fight against the disease. It is performed to treat cancer patients from long, even when the immune system was not well understood by doctors. Major factors that are driving the growth of the market are increasing occurrence of cancer, Changing life style, Smoking and excessive alcoholic intake, high efficacy of immunotherapy compared to other treatments, less side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer. The major factor restraining the growth of the market is various cancer like Melanoma shows resistance towards chemotherapy and radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology.
Cancer immunotherapy market is segmented based on Application into Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others. Based on product type, the market is segmented into Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, BCG and others. Based on Mode of administration, the market is segmented into Intravenous, Oral, Topical, and Intravesical. Based on end users, the market is categorized into hospitals, clinics. Based on Geography, the Cancer immunotherapy market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market due to increased rates of death and morbidity of cancer sufferer and escalating awareness about cancer by the government increases patients treatment. Asia Pacific is expected to emerge as a prominent market due to increased healthcare expenditure in developing countries in this region.
Some of the major companies operating in global Market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co. and Celgene Corp, Immunomedics.
Mode of Administration Introduction Intravenous Oral Topical Intra Vesical
End users Introduction Hospitals Clinics Y-o-Y Growth Analysis, By End users Market Attractiveness Analysis, By End users Market Share Analysis, By End users
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
